Why SciSparc Ltd Stock Is Blasting Higher
Why SciSparc Ltd Stock Is Blasting Higher
Oz Adler, SciSparc's CEO stated, "Our pioneering treatment aims to reduce and alleviate the symptoms of autism along with reducing the side effects that are common when taking cannabis-based treatments, such as CBD."SciSparc Ltd. (NASDAQ:SPRC) shares are trading higher Friday after the company announced it has launched a clinical trial of its combination of cannabidiol (CBD) and SciSparc's proprietary Palmitoylethanolamide, to treat the symptoms of autism spectrum disorder (ASD).
ScisParc Ltd.（纳斯达克股票代码：SPRC）周五股价走高，此前该公司宣布已启动一项针对大麻二酚（CBD）和ScisParc专有的棕榈酰乙醇酰胺组合物的临床试验，以治疗自闭症谱系障碍（ASD）的症状。
The Details:
细节：
SciSparc said that the trial will enroll 60 participants between the ages of 5-18 years old and will measure how SCI-210 compares to standard CBD treatment in managing ASD symptoms.
ScisPARC表示，该试验将招收60名年龄在5-18岁之间的参与者，并将衡量 SCI-210 与标准CBD治疗在控制泛自闭症症状方面的比较。
Oz Adler, SciSparc's CEO stated, "Our pioneering treatment aims to reduce and alleviate the symptoms of autism along with reducing the side effects that are common when taking cannabis-based treatments, such as CBD."
SciParc首席执行官奥兹·阿德勒表示：“我们的开创性疗法旨在减少和缓解自闭症的症状，同时减少服用基于大麻的疗法（例如CBD）时常见的副作用。”
On Wednesday, SciSparc announced the signing of a non-binding letter of intent to merge with a leading vehicle importer company in Israel.
周三，SciParc宣布签署一份不具约束力的意向书，与以色列一家领先的汽车进口公司合并。
Shares of SPRC are up on heavy trading volume Friday. According to data from Benzinga Pro, more than 12.4 million shares have already been traded in the session, compared to the stock's 100-day average of 1.615 million shares.
周五，由于交易量大，SPRC的股价上涨。根据Benzinga Pro的数据，该交易日已经交易了超过1,240万股，而该股的100天平均交易量为161.5万股。
Related News: What's Going On With Rivian Automotive Stock?
相关新闻：Rivian Automotive 股票怎么了？
SPRC Price Action: According to Benzinga Pro, SciSparc shares are up by 53% at $11.35 at the time of publication.
SPRC价格走势：根据Benzinga Pro的数据，截至发布时，SciPARC的股价上涨了53％，至11.35美元。
Image: Bob G from Pixabay
图片：来自 Pixabay 的 Bob G